Abstract
Fucidin is useful against `antibiotic-resistant staphylococci' which are a major problem in causing shunt site infections in patients on chronic intermittent haemodialysis for end-stage renal failure. A new form of intravenous fucidin has been used in vivo in three patients on haemodialysis, and also in experiments in vitro in order to assess its dialysing properties. The experiments in vitro show that some fucidin does cross the dialyser membrane but, in the patients studied, adequate serum levels were maintained throughout a 10-hour haemodialysis. A single intravenous dose of Fucidin is, therefore, adequate for treating `antibiotic-resistant' staphylococcal infections in patients during haemodialysis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARBER M., WATERWORTH P. M. Antibacterial activity in vitro of fucidin. Lancet. 1962 May 5;1(7236):931–932. doi: 10.1016/s0140-6736(62)91969-4. [DOI] [PubMed] [Google Scholar]
- GODTFREDSEN W., ROHOLT K., TYBRING L. Fucidin: a new orally active antibiotic. Lancet. 1962 May 5;1(7236):928–931. doi: 10.1016/s0140-6736(62)91968-2. [DOI] [PubMed] [Google Scholar]
- PORTER I. A., WILSON J. S. STAPHYLOCOCCAL INFECTIONS TREATED WITH FUSIDIC ACID IN NURSES. Lancet. 1963 Sep 28;2(7309):658–659. doi: 10.1016/s0140-6736(63)90453-7. [DOI] [PubMed] [Google Scholar]
- Rolinson G. N., Sutherland R. The binding of antibiotics to serum proteins. Br J Pharmacol Chemother. 1965 Dec;25(3):638–650. doi: 10.1111/j.1476-5381.1965.tb01788.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simpson K. M., Blainey J. D., Dawson-Edwards P., Hilton D. D., Williams B. T. The twin minicoil artificial kidney. Lancet. 1967 Jun 10;1(7502):1244–1247. doi: 10.1016/s0140-6736(67)92712-2. [DOI] [PubMed] [Google Scholar]